Clinical trial
A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel(Neuronata-R® Inj.) in Patients With Amyotrophic Lateral Sclerosis
NCT04745299 is registered in ClinicalTrials.gov with Corestemchemon, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel(Neuronata-R® Inj.) in Patients With Amyotrophic Lateral Sclerosis
- Lead sponsor
- Corestemchemon, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 24, 2021
- Completion date
- November 13, 2024
- Enrollment
- 123 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.